Spots Global Cancer Trial Database for adenocarcinoma of the colon
Every month we try and update this database with for adenocarcinoma of the colon cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Antineoplaston Therapy in Treating Patients With Colon Cancer | NCT00003486 | Stage IV Colon ... Recurrent Colon... Adenocarcinoma ... | antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation... | 18 Years - | National Cancer Institute (NCI) | |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | NCT00062426 | Colorectal Canc... | bevacizumab capecitabine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00080951 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00004870 | Colorectal Canc... | oblimersen sodi... irinotecan hydr... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer | NCT00006103 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... | - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | NCT00004150 | Colorectal Canc... | fluorouracil leucovorin calc... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | NCT00026273 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | Pfizer | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | NCT00262808 | Colorectal Canc... | sargramostim fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | University of Rochester | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab | NCT04554836 | Adenocarcinoma ... Adenocarcinoma ... | Cetuximab FOLFIRI | 18 Years - 99 Years | TheraOp | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer | NCT00899210 | Colorectal Canc... Metastatic Canc... | laboratory biom... cryosurgery radiofrequency ... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
| Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | NCT00647530 | Colorectal Canc... | panitumumab capecitabine fluorouracil oxaliplatin | 18 Years - | University of Birmingham | |
| BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00022477 | Colorectal Canc... | BMS-247550 | 18 Years - | University of Chicago | |
| Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | NCT00048971 | Colorectal Canc... Diarrhea Neutropenia | mutation analys... polymorphic mic... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | NCT00075595 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Genetic Study in Patients With Stage II or Stage III Colon Cancer | NCT00003833 | Colorectal Canc... | DNA stability a... gene mapping | - 69 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer | NCT05197322 | Adenocarcinoma ... | Pembrolizumab | 18 Years - | University College, London | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | NCT00265811 | Colorectal Canc... | Folfox Cetuximab | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer | NCT00087256 | Colorectal Canc... | Celecoxib placebo | 18 Years - | NSABP Foundation Inc | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | NCT00707889 | Advanced Colore... Adenocarcinoma ... Adenocarcinoma ... | ABT-869 bevacizumab oxaliplatin folinic acid fluorouracil ABT-869 | 18 Years - | AbbVie | |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
| Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | NCT00958737 | Colorectal Canc... | FOLFOX regimen CAPOX | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy | NCT00918827 | Colorectal Canc... | - | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | ||
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | NCT00062348 | Colorectal Canc... Head and Neck C... Metastatic Canc... | boronophenylala... sodium borocapt... conventional su... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00004870 | Colorectal Canc... | oblimersen sodi... irinotecan hydr... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | NCT00433576 | Adenocarcinoma ... Adenocarcinoma ... Stage I Colon C... Stage I Rectal ... Stage II Colon ... Stage II Rectal... Stage III Colon... Stage III Recta... | resveratrol pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer | NCT00028626 | Colorectal Canc... Metastatic Canc... | embolization th... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | NCT00003220 | Colorectal Canc... | bryostatin 1 | - | Barbara Ann Karmanos Cancer Institute | |
| Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00098787 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... Oxaliplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer | NCT00408772 | Colorectal Canc... Metastatic Canc... | bevacizumab capecitabine oxaliplatin conventional su... neoadjuvant the... radiofrequency ... | 18 Years - 120 Years | University of California, Davis | |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00003594 | Colorectal Canc... | irinotecan fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer | NCT00056030 | Colorectal Canc... Metastatic Canc... | cetuximab fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | NCT00077259 | Colorectal Canc... | epothilone D | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | NCT00268398 | Colorectal Canc... Metastatic Canc... Chemotherapy | oxaliplatin, fo... oxaliplatin, ir... | 18 Years - 75 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer | NCT00003753 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine irinotecan hydr... adjuvant therap... conventional su... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Colon Cancer | NCT00046995 | Colorectal Canc... | carboplatin fluorouracil leucovorin calc... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT00467142 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... polymorphism an... | 18 Years - 120 Years | Institut Bergonié | |
| Genetic Study in Patients With Stage II or Stage III Colon Cancer | NCT00003833 | Colorectal Canc... | DNA stability a... gene mapping | - 69 Years | Alliance for Clinical Trials in Oncology | |
| Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | NCT00002575 | Colorectal Canc... | conventional su... laparoscopic su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Genetic Study of Familial Factors in Patients With Colon Cancer | NCT00055848 | Colorectal Canc... | cytogenetic ana... gene mapping microarray anal... | - 70 Years | Alliance for Clinical Trials in Oncology | |
| MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer | NCT00602329 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
| Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00098787 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... Oxaliplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | NCT00002997 | Colorectal Canc... Metastatic Canc... | cryosurgery | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy | NCT01099449 | Chemotherapeuti... Colorectal Canc... Neuropathy Neurotoxicity | calcium glucona... magnesium sulfa... placebo oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | NCT00410579 | Colorectal Canc... Fatigue Long-term Effec... Pain Psychosocial Ef... | Telephone inter... | - | NSABP Foundation Inc | |
| Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00005085 | Colorectal Canc... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Prospective Study of Oncologic Outcomes After Laparoscopic Modified Complete Mesocolic Excision for Non-metastatic Right Colon Cancer [PIONEER Study] | NCT03992599 | Adenocarcinoma ... | Laparoscopic mo... | 19 Years - | Yonsei University | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
| G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | NCT00541125 | Colorectal Canc... | bevacizumab filgrastim fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection | NCT05077358 | Adenocarcinoma ... | Intracorporeal ... Extracorporeal ... | 19 Years - | Yonsei University | |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | NCT00016978 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | NCT00290615 | Colorectal Canc... | bevacizumab cetuximab capecitabine oxaliplatin | 18 Years - | Duke University | |
| Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment | NCT00126867 | Colon Cancer | 18 Years - | AHS Cancer Control Alberta |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
